Ranbaxy

In a published report, JP Morgan says Teva Pharmaceutical (NASDAQ: TEVA) is expected to benefit from the generic Lipitor situation, as the company is announced to receive a potion of profits during period of exclusivity. JPM says, “While terms of the agreement with Ranbaxy are undisclosed...

On November 30, Pfizer's (NYSE: PFE) blockbuster drug Lipitor will face generic competition. Lipitor, a cholesterol drug, is the best selling drug of all time. An Indian company called Ranbaxy Laboratories will begin selling a generic version of the drug (atorvastatin) at the end of the month after...